A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

Dombret, Hervé; Chastang, Claude; Fenaux, Pierre; Reiffers, Josy; Bordessoule, Dominique; Bouabdallah, Réda; Mandelli, Franco; Ferrant, Augustin; Auzanneau, G; Tilly, Hervé; Yver, Antoine; Degos, Laurent

doi:10.1056/nejm199506223322504

Public

A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

Published in New England Journal of Medicine • Jun 22, 1995

Authors:

Hervé Dombret

Claude Chastang

Pierre Fenaux

Abstract

BACKGROUND: Intensive chemotherapy for acute myelogenous leukemia (AML) continues to yield low rates of complete remission and survival among patients over the age of 65 years. Infection-related mortality is particularly high among these patients during the period of neutropenia that follows chemoth...

Subject

Medicine

Neutropenia

Cytarabine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!